Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the safety of oral ifetroban compared to
placebo as measured by a > 20% decrease in FEV1 compared to baseline following a dose of
Investigational Medicinal Product (IMP) (Study Day 1 or 2) prior to initiation of the aspirin
challenge.